Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma.

With increasing tumor size, the IL-7R level exhibited a decreasing trend ( Figure 3 E) and the CA19-9 level showed an increasing trend ( Figure 3 F).

also in 47,180 other papers